Four genetic loci influencing electrocardiographic indices of left ventricular hypertrophy
- PMID: 21965548
- PMCID: PMC5291170
- DOI: 10.1161/CIRCGENETICS.111.960203
Four genetic loci influencing electrocardiographic indices of left ventricular hypertrophy
Abstract
Background: Presence of left ventricular hypertrophy on an ECG (ECG-LVH) is widely assessed clinically and provides prognostic information in some settings. There is evidence for significant heritability of ECG-LVH. We conducted a large-scale gene-centric association analysis of 4 commonly measured indices of ECG-LVH.
Methods and results: We calculated the Sokolow-Lyon index, Cornell product, 12-lead QRS voltage sum, and 12-lead QRS voltage product in 10 256 individuals from 3 population-based cohorts and typed their DNA using a customized gene array (the Illumina HumanCVD BeadChip 50K array), containing 49 094 genetic variants in ≈2100 genes of cardiovascular relevance. We followed-up promising associations in 11 777 additional individuals. We identified and replicated 4 loci associated with ECG-LVH indices: 3p22.2 (SCN5A, rs6797133, P=1.22 × 10(-7)) with Cornell product and 12q13.3 (PTGES3, rs2290893, P=3.74 × 10(-8)), 15q25.2 (NMB, rs2292462, P=3.23 × 10(-9)), and 15q26.3 (IGF1R, rs4966014, P=1.26 × 10(-7)) with the 12-lead QRS voltage sum. The odds ratio of being in the top decile for the 12-lead QRS voltage sum for those carrying 6 trait-raising alleles at the 12q13.3, 15q25.2, and 15q26.3 loci versus those carrying 0 to 1 alleles was 1.60 (95% CI: 1.20 to 2.29). Lead single-nucleotide polymorphisms at the 12q13.3 and 15q25.2 loci showed significant expression quantitative trait loci effects in monocytes.
Conclusions: These findings provide novel insights into the genetic determination of ECG-LVH. The findings could help to improve our understanding of the mechanisms determining this prognostically important trait.
Figures
Comment in
-
What can genetic studies of left ventricular mass tell us?Circ Cardiovasc Genet. 2011 Dec;4(6):581-4. doi: 10.1161/CIRCGENETICS.111.961839. Circ Cardiovasc Genet. 2011. PMID: 22187447 Free PMC article. No abstract available.
Similar articles
-
Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.J Electrocardiol. 2009 Nov-Dec;42(6):584-8. doi: 10.1016/j.jelectrocard.2009.06.020. Epub 2009 Jul 24. J Electrocardiol. 2009. PMID: 19631946
-
Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.J Electrocardiol. 2014 Sep-Oct;47(5):630-5. doi: 10.1016/j.jelectrocard.2014.07.003. Epub 2014 Jul 3. J Electrocardiol. 2014. PMID: 25052475 Review.
-
Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.Clin Exp Hypertens. 2010 May;32(3):145-53. doi: 10.3109/10641960903254455. Clin Exp Hypertens. 2010. PMID: 20504121
-
ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.Int J Cardiol. 2019 Feb 1;276:125-129. doi: 10.1016/j.ijcard.2018.09.104. Epub 2018 Sep 27. Int J Cardiol. 2019. PMID: 30293667
-
Prediction of stroke with electrocardiographic left ventricular hypertrophy in hypertensive patients: A meta-analysis.J Electrocardiol. 2020 Jul-Aug;61:27-31. doi: 10.1016/j.jelectrocard.2020.04.018. Epub 2020 Apr 28. J Electrocardiol. 2020. PMID: 32504899 Review.
Cited by
-
Connecting intermediate phenotypes to disease using multi-omics in heart failure.medRxiv [Preprint]. 2024 Aug 7:2024.08.06.24311572. doi: 10.1101/2024.08.06.24311572. medRxiv. 2024. PMID: 39148828 Free PMC article. Preprint.
-
Genome-wide association analysis of left ventricular imaging-derived phenotypes identifies 72 risk loci and yields genetic insights into hypertrophic cardiomyopathy.Nat Commun. 2023 Nov 30;14(1):7900. doi: 10.1038/s41467-023-43771-5. Nat Commun. 2023. PMID: 38036550 Free PMC article.
-
What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?J Cardiovasc Dev Dis. 2022 Apr 21;9(5):124. doi: 10.3390/jcdd9050124. J Cardiovasc Dev Dis. 2022. PMID: 35621835 Free PMC article. Review.
-
Novel SCN5A and GPD1L Variants Identified in Two Unrelated Han-Chinese Patients With Clinically Suspected Brugada Syndrome.Front Cardiovasc Med. 2021 Dec 8;8:758903. doi: 10.3389/fcvm.2021.758903. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34957250 Free PMC article.
-
SD + SV4 diagnosis of left ventricular hypertrophy, a revaluation of ECG criterion by cardiac magnetic resonance imaging.Ann Noninvasive Electrocardiol. 2021 Jul;26(4):e12832. doi: 10.1111/anec.12832. Epub 2021 Feb 23. Ann Noninvasive Electrocardiol. 2021. PMID: 33620147 Free PMC article.
References
-
- Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Int Med. 1969;71:89–105. - PubMed
-
- Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004;292:2343–2350. - PubMed
-
- Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161–186. - PubMed
-
- Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation. 1987;75:565–572. - PubMed
-
- Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995;25:417–423. - PubMed
Publication types
MeSH terms
Grants and funding
- RG/08/013/25942/BHF_/British Heart Foundation/United Kingdom
- RG/08/008/25291/BHF_/British Heart Foundation/United Kingdom
- DH_/Department of Health/United Kingdom
- G0902313/MRC_/Medical Research Council/United Kingdom
- G0902037/MRC_/Medical Research Council/United Kingdom
- R01 HL105756/HL/NHLBI NIH HHS/United States
- R01 AG013196/AG/NIA NIH HHS/United States
- HS06516/HS/AHRQ HHS/United States
- PG/07/133/24260/BHF_/British Heart Foundation/United Kingdom
- RG/07/008/23674/BHF_/British Heart Foundation/United Kingdom
- G19/35/MRC_/Medical Research Council/United Kingdom
- G8802774/MRC_/Medical Research Council/United Kingdom
- R01 HL036310/HL/NHLBI NIH HHS/United States
- G0100222/MRC_/Medical Research Council/United Kingdom
- PG/07/131/24254/BHF_/British Heart Foundation/United Kingdom
- AG13196/AG/NIA NIH HHS/United States
- HL36310/HL/NHLBI NIH HHS/United States
- G0600705/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Miscellaneous
